Artificial Intelligence in the ICU
GAINESVILLE, Fla. (Ivanhoe Newswire)— At one time another, almost all ICUs across the country have…More
Yearly Archives: 2022
Aristada Drug for Schizophrenia
NASHVILLE, Tenn. (Ivanhoe Newswire)— More than three million people in the U.S. are living with…More
Injectrode to Better Treat Neurodegenerative Diseases
MADISON, Wisc. (Ivanhoe Newswire)— Neuromodulation therapies involve medical devices that can treat several chronic conditions,…More
Spring Break Deals: Insider Travel Tips
ORLANDO, FLA. (Ivanhoe Newswire)– With more than 60 percent of the U.S. population vaccinated more…More
Digital EyeStrain: How to Prevent
ORLANDO, FLA. (Ivanhoe Newswire)– Nearly two out of three people in the U.S. experience symptoms…More
Six Dangerous Retirement Mistakes
ORLANDO, FLA. (Ivanhoe Newswire)– A new study from the employment benefit research institute found about…More
Screen Time and Kids?
ORLANDO, FLA. (Ivanhoe Newswire)– Screen time and kids is a hot topic. Studies show children…More
Better Ovarian Cancer Treatment: Thank the Sonic Hedgehog Gene?
PITTSBURGH, Penn. (Ivanhoe Newswire)— For many ovarian cancer patients, doctors usually recommend surgery and chemotherapy.…More
OptiLight for Dry Eye
NASHVILLE, Tenn. (Ivanhoe Newswire)— About 16 million adults are living with dry eye disease in…More
Spinal Cord Stimulation: Jerod’s Victories Over Paralysis
LOUISVILLE, Ky. (Ivanhoe Newswire)— For the past decade, researchers have studied the impact of epidural…More